Find News

Filter articles

Applied Filters

Showing 1 to 10 of 272 results

BGI hit with $8m damages bill in patent dispute with Illumina

02-12-2021Muireann Bolger

Illumina has secured an $8 million damages verdict against China-based BGI Genomics, and its US subsidiary, MGI, in a dispute involving gene-sequencing patents.

WIPO unveils course on genetic resources in the life sciences

International06-05-2021Muireann Bolger

The World Intellectual Property Office has launched a course on IP and genetic resources in the life sciences.

Fed Circ. affirms Stanford genetics patent rejection

US26-03-2021Alex Baldwin

The Federal Circuit has affirmed a Patent Trial and Appeal Board decision denying Stanford University a patent application for calculating parent genes.

Fed Circuit rejects Stanford Uni’s ‘abstract’ genetics patent

US15-03-2021Rory O'Neill

Stanford University can’t patent a genetic testing method as it is based on “abstract mathematical calculations”, the US Court of Appeals for the Federal Circuit has ruled.

Zebrafish start-up secures CRISPR licence

International18-02-2021Rory O'Neill

ERS Genomics has agreed to license CRISPR-Cas9 technology to a Barcelona-based start-up which uses a zebrafish-based research model.

Illumina wins PTAB appeal over Columbia DNA patents

US02-02-2021Alex Baldwin

Biotech company Illumina has won a dispute with Columbia University, after the Court of Appeals for the Federal Circuit backed an earlier ruling that the university’s DNA-sequencing patents were invalid.

Roche urges SCOTUS to cancel Illumina patent win

US08-01-2021Rory O'Neill

Roche has asked the US Supreme Court to declare that methods of separating DNA are not patent-eligible.

Ravgen and Myriad in patent dispute over DNA testing tech


Biotechnology company Ravgen has accused Myriad Genetics and Myriad Women’s Health of infringing two patents covering non-invasive DNA testing technology.

Eli Lilly seals $1bn genetics deal

17-12-2020Rory O'Neill

Eli Lilly is expanding its genetics business with the $880 million purchase of Prevail Therapeutics, in a deal that could rise to more than $1 billion.

Illumina, Roche accused of infringing genetic testing patents

US07-12-2020Muireann Bolger

Pharmaceutical companies Illumina and Roche have been sued for allegedly infringing two patents covering the technology for non-invasive DNA testing by Maryland genetic testing company Ravgen.

Showing 1 to 10 of 272 results